CD36 and melanoma: Together, these data are consistent with previous observations that not only BRAFis but also MEKis induce CD36 expression in melanoma cells (7) and that the CD36+ SMC state is an important transitory state leading to the emergence of other MAPKi-tolerant states, which promote resistance (19).